Status:
UNKNOWN
Optical Coherence Tomography Angiography and in Fluorescein Angiography in Diabetic Retinopathy
Lead Sponsor:
Assiut University
Conditions:
OctA .FFA Findings in DR
Eligibility:
All Genders
45-75 years
Brief Summary
Diabetic retinopathy (DR) is the leading cause of decreased vision in working age people. Patients with DR can develop macular edema and proliferative retinopathy which are major causes of visual impa...
Eligibility Criteria
Inclusion
- All Pts with confirmed type 2 diabetes of at least 6 months. Best corrected visual Acuity of 6/60 or higher (using asnellen chart) in each eye
Exclusion
- Dense media opacities interfere with image FFA as dense cataract . Previous TTT mainly retinal laser photocoagulation or intra vitreal injection. History of ocular disease as glaucoma and retinal vascular occlusion . Previous ocular surgery.
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05190965
Start Date
September 1 2022
End Date
February 1 2024
Last Update
January 13 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.